Page 1227 - Cote clinical veterinary advisor dogs and cats 4th

Lymphoma Rescue Therapy 613.e1

ADDITIONAL SUGGESTED RELATED CLIENT EDUCATION
READINGS SHEETS
VetBooks.ir Bergman PJ: Mechanisms of anticancer drug Consent to Administer Chemotherapy Diseases and Disorders
resistance. Vet Clin North Am Small Anim Pract
Lymphoma, Gastrointestinal
33:651-667, 2003.
Bergman PJ, et al: Monoclonal antibody C219
immunohistochemistry against P-glycoprotein: Lymphoma, Peripheral or Multicentric
sequential analysis and predictable ability in dogs
with lymphoma. J Vet Intern Med 10(6):354-359,
1996.
Brenn SH, et al: Evaluation of P-glycoprotein expres-
sion in feline lymphoma and its correlation with
clinical outcome. Vet Comp Oncol 6(3):201-211,
2008.
Elliott JW, et al: Thymidine kinase assay in canine
lymphoma. Vet Comp Oncol 11(1):1-13, 2013.
Flory AB, et al: Evaluation of factors associated
with second remission in dogs with lymphoma
undergoing retreatment with cyclophosphamide,
doxorubicin, vincristine, and prednisone chemo-
therapy protocol: 95 cases (2000-2007). J Am Vet
Med Assoc 238:501-506, 2011.
Moore AS, et al: The expression of P-glycoprotein in
canine lymphoma and its association with multidrug
resistance. Cancer Invest 13:475-479, 1995.
Vail DM, et al: Hematopoietic tumors: canine
lymphoma and lymphoid leukemias. In Withrow
SJ, et al, editors: Small animal clinical oncology, ed
5, St. Louis, 2013, Elsevier Saunders, pp 608-638.

www.ExpertConsult.com